Daniel Clark
Stock Analyst at Leerink Partners
(2.80)
# 1,663
Out of 5,154 analysts
8
Total ratings
83.33%
Success rate
27.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Maintains: Outperform | $26 → $30 | $23.92 | +25.42% | 3 | Feb 24, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $618.92 | -3.06% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $122.23 | +26.81% | 2 | Jul 17, 2025 |
Elanco Animal Health
Feb 24, 2026
Maintains: Outperform
Price Target: $26 → $30
Current: $23.92
Upside: +25.42%
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $618.92
Upside: -3.06%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $122.23
Upside: +26.81%